Tri Locum Partners’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Tri Locum Partners’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,268	Closed	-$396K	–	92
2023 Q2	$396K	Buy	+15,268	New	+$357K	0.15%	44
2022 Q2	–	Sell	-406,733	Closed	-$9.06M	–	67
2022 Q1	$9.06M	Buy	406,733 +193,559	+91%	+$4.94M	3.54%	11
2021 Q4	$9.31M	Buy	+213,174	New	+$8.52M	3.66%	12

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tri Locum Partners's INBX Position: Q3 2023 in Review

Tri Locum Partners sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 15,268 shares — an estimated $396K sold.

Tri Locum Partners first reported a position in INBX in Q4 2021 and held it in 3 quarters. The position peaked at $9.31M in Q4 2021. 111 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

Tri Locum Partners reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Tri Locum Partners sold 15,268 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $396K.
Tri Locum Partners first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Tri Locum Partners's Inhibrx, Inc. Common Stock position peaked at $9.31M in Q4 2021.
111 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on Tri Locum Partners's 13F filing for Q3 2023, filed 14 Nov 2023.